Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the class of organic compounds known as 1-benzoylpiperidines, characterized by a piperidine ring and a benzonitrile moiety. It has been primarily studied as an experimental research tool and is not approved for clinical use. The molecule has been investigated for its ability to inhibit nitric oxide synthase (NOS), including isoforms such as neuronal NOS (NOS1), inducible NOS (NOS2), and endothelial NOS (NOS3). By inhibiting these enzymes, it may modulate nitric oxide production, which plays roles in vascular tone regulation, neurotransmission, and immune response. Its primary applications are in biochemical research rather than therapeutic use[1][2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile.